In their study, massive tumor regression after chemotherapy were observed only in the triple-negative and HER2-positive tumors, and the presence of residual tumors in surgical specimens after NAC in ER-positive/HER2-negative tumors was not correlated with the change in largest diameter of late enhancement during NAC. Here, ERBB2 is linked to neoplasm.